- Book
- August 2022
- 496 Pages
- Book
- April 2021
- 544 Pages
- Book
- August 2018
- 376 Pages
- Book
- August 2018
- 1524 Pages
- Book
- June 2018
- 208 Pages
- Book
- May 2016
- 512 Pages
- Book
- April 2016
- 214 Pages
Global
- Book
- January 2016
- 288 Pages
- Book
- February 2015
- 288 Pages
- Book
- April 2014
- 744 Pages
- Book
- February 2013
- 232 Pages
- Book
- October 2011
- 360 Pages
Europe
- Book
- October 2010
- 200 Pages
- Book
- July 2009
- 1116 Pages
- Book
- April 2024
- 1280 Pages
Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures.
The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy.
Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more